Revenue: The sum of all revenue fields included for a company's operating activities.
Kymera Therapeutics, Inc. (KYMR) had Revenue of $22.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$22.10M |
$-65.58M |
|
-- |
|
$22.10M |
|
$96.53M |
|
$-74.43M |
|
$8.85M |
|
$-65.58M |
|
$-65.58M |
|
$-65.58M |
|
$-65.58M |
|
$-65.58M |
|
$-65.58M |
|
$-74.43M |
|
$-74.90M |
|
80.15M |
|
80.15M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$500.95M |
|
$49.17M |
|
$417.36M |
|
$918.31M |
|
$58.99M |
|
$1.91M |
|
$73.09M |
|
$132.08M |
|
$786.23M |
|
$786.23M |
|
$786.23M |
|
65.11M |
|
| Cash Flow Statement Financials | |
$-79.15M |
|
$48.62M |
|
$0.26M |
|
$126.05M |
|
$95.77M |
|
$-30.28M |
|
$14.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.49 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-336.77% |
|
-336.77% |
|
-- |
|
-296.75% |
|
-296.75% |
|
$-79.62M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-8.34% |
|
-8.34% |
|
-7.14% |
|
-8.32% |
|
$12.07 |
|
$-0.99 |
|
$-0.99 |
|